Android app Apple app link

Mesoblast's Ryoncil Gains Permanent CMS J-Code for Billing and Reimbursement

By Yahoo! Finance   |   1 month ago
Mesoblast's Ryoncil Gains Permanent CMS J-Code for Billing and Reimbursement

Mesoblast Limited (NASDAQ:MESO) achieved a significant milestone with the assignment of a specific J-Code by CMS for its product Ryoncil. This facilitates reimbursement and broader patient access.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.